Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Total Non-Current Liabilities: 2018-2020

Historic Total Non-Current Liabilities for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $58.4 million.

  • Genmab A's Total Non-Current Liabilities rose 9.29% to $116.99 in Q2 2023 from the same period last year, while for Jun 2023 it was $116.99, marking a year-over-year increase of 9.29%. This contributed to the annual value of $58.4 million for FY2020, which is 2061.10% up from last year.
  • Per Genmab A's latest filing, its Total Non-Current Liabilities stood at $58.4 million for FY2020, which was up 2,061.10% from $2.7 million recorded in FY2019.
  • Genmab A's 5-year Total Non-Current Liabilities high stood at $58.4 million for FY2020, and its period low was $363,751 during FY2018.
  • Over the past 3 years, Genmab A's median Total Non-Current Liabilities value was $2.7 million (recorded in 2019), while the average stood at $20.5 million.
  • Data for Genmab A's Total Non-Current Liabilities shows a peak YoY surged of 2,061.10% (in 2020) over the last 5 years.
  • Genmab A's Total Non-Current Liabilities (Yearly) stood at $363,751 in 2018, then spiked by 643.33% to $2.7 million in 2019, then soared by 2,061.10% to $58.4 million in 2020.